Phase IC Study of Safety and PK of SQ109 300mg Daily
Clinical trial NCT01358162 · COMPLETED
Trial details
- NCT number
- NCT01358162
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-02-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.